Benjamin G. Barwick
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Epigenetics and DNA Methylation 15
- Protein Degradation and Inhibitors 10
- Ubiquitin and proteasome pathways 7
- Hematology 27
- Multiple Myeloma Research and Treatments 27
- Co-authors
- Jeremy M. Boss (16 shared papers)Christopher D. Scharer (13 shared papers)Lawrence Boise (31 shared papers)Paula M. Vertino (14 shared papers)Alexander P. R. Bally (6 shared papers)Vikas A. Gupta (15 shared papers)Sagar Lonial (25 shared papers)Karen N. Conneely (4 shared papers)
- Journals
- Blood (16 papers)The Journal of Immunology (8 papers)Nature Communications (5 papers)Blood Advances (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Benjamin G. Barwick
72 papers receiving 3.0k citations
Benjamin G. Barwick's Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 515
- Immunology 829
- Oncology 742
- Cancer Research 359
- Molecular Biology 1.7k
Countries citing papers authored by Benjamin G. Barwick
This map shows the geographic impact of Benjamin G. Barwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin G. Barwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin G. Barwick more than expected).
Fields of papers citing papers by Benjamin G. Barwick
This network shows the impact of papers produced by Benjamin G. Barwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin G. Barwick. The network helps show where Benjamin G. Barwick may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin G. Barwick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 288 | |
| 2 | 2013 | 218 | |
| 3 | CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor Hit paper breakdown → | 2022 | 182 |
| 4 | 2013 | 162 | |
| 5 | 2012 | 139 | |
| 6 | 2019 | 125 | |
| 7 | 2019 | 115 | |
| 8 | 2019 | 113 | |
| 9 | 2016 | 106 | |
| 10 | 2020 | 103 | |
| 11 | 2017 | 100 | |
| 12 | 2018 | 96 | |
| 13 | 2019 | 96 | |
| 14 | 2018 | 89 | |
| 15 | 2020 | 77 | |
| 16 | 2016 | 72 | |
| 17 | 2013 | 63 | |
| 18 | 2017 | 62 | |
| 19 | 2016 | 62 | |
| 20 | 2021 | 56 |
About Benjamin G. Barwick
Benjamin G. Barwick is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Cancer Research, having authored 74 papers that have together received 3.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (27 papers), Epigenetics and DNA Methylation (15 papers), Immune Cell Function and Interaction (15 papers), Protein Degradation and Inhibitors (10 papers), T-cell and B-cell Immunology (9 papers), Ubiquitin and proteasome pathways (7 papers), Immunotherapy and Immune Responses (7 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Hematology (515 citations), Immunology (829 citations), Oncology (742 citations), Cancer Research (359 citations) and Molecular Biology (1.7k citations). Benjamin G. Barwick has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Jeremy M. Boss, Christopher D. Scharer, Lawrence Boise, Paula M. Vertino, Alexander P. R. Bally, Vikas A. Gupta, Sagar Lonial, Karen N. Conneely, Glen A. Satten and Pankaj Chopra. Their work appears in journals such as Blood, The Journal of Immunology, Nature Communications, Blood Advances and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.